Daruwala Paul 4
4 · Cidara Therapeutics, Inc. · Filed Sep 13, 2022
Insider Transaction Report
Form 4
Daruwala Paul
Chief Medical Officer
Transactions
- Sale
Common Stock
2022-09-12$0.68/sh−16,199$11,095→ 221,099 total
Footnotes (1)
- [F1]Represents shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock units on September 10, 2022. These sales are mandated by the Reporting Person's election to require the satisfaction of a tax withholding obligation to be funded by a "sell to cover" transaction and do not represent discretionary trades by the Reporting Person.